mvasi

Generic: bevacizumab-awwb

Labeler: amgen inc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name mvasi
Generic Name bevacizumab-awwb
Labeler amgen inc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

bevacizumab 100 mg/4mL

Manufacturer
Amgen Inc

Identifiers & Regulatory

Product NDC 55513-206
Product ID 55513-206_7fa722d1-29fa-4771-9fe5-5c8c74cf2673
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761028
Listing Expiration 2026-12-31
Marketing Start 2018-06-01

Pharmacologic Class

Established (EPC)
vascular endothelial growth factor inhibitor [epc]
Mechanism of Action
vascular endothelial growth factor-directed antibody interactions [moa] vascular endothelial growth factor inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55513206
Hyphenated Format 55513-206

Supplemental Identifiers

RxCUI
2046140 2046145 2046148 2046149
UNII
2S9ZZM9Q9V
NUI
N0000193543 N0000178291 N0000193542

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name mvasi (source: ndc)
Generic Name bevacizumab-awwb (source: ndc)
Application Number BLA761028 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 100 mg/4mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (55513-206-01) / 4 mL in 1 VIAL
  • 1 VIAL in 1 CARTON (55513-206-21) / 4 mL in 1 VIAL
source: ndc

Packages (2)

55513-206-01 1 VIAL in 1 CARTON (55513-206-01) / 4 mL in 1 VIAL 55513-206-21 1 VIAL in 1 CARTON (55513-206-21) / 4 mL in 1 VIAL

Ingredients (1)

bevacizumab (100 mg/4mL)

Linked Drug Pages (1)

MVASI ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "7fa722d1-29fa-4771-9fe5-5c8c74cf2673", "openfda": {"nui": ["N0000193543", "N0000178291", "N0000193542"], "unii": ["2S9ZZM9Q9V"], "rxcui": ["2046140", "2046145", "2046148", "2046149"], "spl_set_id": ["0a562b4e-67ce-4bab-852c-d9ee71e55fb8"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["Amgen Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (55513-206-01)  / 4 mL in 1 VIAL", "package_ndc": "55513-206-01", "marketing_start_date": "20180601"}, {"sample": false, "description": "1 VIAL in 1 CARTON (55513-206-21)  / 4 mL in 1 VIAL", "package_ndc": "55513-206-21", "marketing_start_date": "20250627"}], "brand_name": "MVASI", "product_id": "55513-206_7fa722d1-29fa-4771-9fe5-5c8c74cf2673", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]", "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]"], "product_ndc": "55513-206", "generic_name": "bevacizumab-awwb", "labeler_name": "Amgen Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "MVASI", "active_ingredients": [{"name": "BEVACIZUMAB", "strength": "100 mg/4mL"}], "application_number": "BLA761028", "marketing_category": "BLA", "marketing_start_date": "20180601", "listing_expiration_date": "20261231"}